A Survey on Patients' Opinions of Alternative Drug Delivery Systems for the Treatment of Glaucoma in South-South Nigeria

Overview

Journal Middle East Afr J Ophthalmol

Specialty Ophthalmology

Date 2024 Jan 1

PMID 38162567

Authors

Chigozie I Echieh

Karl Mercieca

Ugochukwu A Eze

Constance Weber

Adedeji Akinyemi

Affiong A Ibanga

Chidiebere P Echieh

Affiliations

Soon will be listed here.

Abstract

Purpose: Despite the human ocular surface being easily accessible, ocular drug delivery can be challenging. When applied improperly, topical medications, the most popular first-line treatment used to treat glaucoma, can have a very brief contact time with the ocular surface and may not have the desired therapeutic impact. Drug delivery devices are gadgets that can address some of these problems. This study aims to determine patients' opinions on ocular drug delivery devices used in the treatment of primary open-angle glaucoma (POAG).

Methods: A pretested interviewer-administered questionnaire was used in a cross-sectional study of 115 POAG patients recruited from outpatient clinics in two Nigerian tertiary health institutions. Participants were asked about their understanding and acceptance of five Ocular drug delivery systems (ODD), namely drug-emitting contact lenses (CL), punctual plugs, subconjunctival injections, intracameral implants, and trabecular meshwork micro-stents, for the treatment of POAG.

Results: Sixty (52.2%) participants, whose average age was 50 ± 9.8 years, were men. Self-pay was used for eye health treatments by 65% of participants. Of the participants, 68.7% admitted to using eye drops on their own. 57% of people were said to take their glaucoma medications consistently. CL and subconjunctival implants were seen to be most acceptable according to 39% and 30% of participants, respectively. Major factors determining the acceptability of ODD for POAG treatment were observed to be cost and effectiveness.

Conclusion: Patients in our cohort who are being treated for POAG have a fairly positive attitude towards ODD. The prospective use of these devices for POAG treatment in Nigeria will depend on their efficacy and cost, as well as how ophthalmologists will weigh ODD options.

References

Ozdemir S, Wong T, Allingham R, Finkelstein E . Predicted patient demand for a new delivery system for glaucoma medicine. Medicine (Baltimore). 2017; 96(15):e6626. PMC: 5403112. DOI: 10.1097/MD.0000000000006626. View

Lavik E, Kuehn M, Kwon Y . Novel drug delivery systems for glaucoma. Eye (Lond). 2011; 25(5):578-86. PMC: 3171267. DOI: 10.1038/eye.2011.82. View

Friedman D, Quigley H, Gelb L, Tan J, Margolis J, Shah S . Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007; 48(11):5052-7. DOI: 10.1167/iovs.07-0290. View

Weber C, Quintin P, Holz F, Fea A, Mercieca K . Ocular drug delivery systems: glaucoma patient perceptions from a German university hospital eye clinic. Graefes Arch Clin Exp Ophthalmol. 2023; 262(2):545-556. PMC: 10844344. DOI: 10.1007/s00417-023-06248-1. View

Adio A, Onua A . Economic burden of glaucoma in Rivers State, Nigeria. Clin Ophthalmol. 2012; 6:2023-31. PMC: 3526906. DOI: 10.2147/OPTH.S37145. View

Chan H, Wong T, Lamoureux E, Perera S . A Survey on the Preference of Sustained Glaucoma Drug Delivery Systems by Singaporean Chinese Patients: A Comparison Between Subconjunctival, Intracameral, and Punctal Plug Routes. J Glaucoma. 2015; 24(7):485-92. DOI: 10.1097/IJG.0000000000000197. View

Quigley H, Broman A . The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006; 90(3):262-7. PMC: 1856963. DOI: 10.1136/bjo.2005.081224. View

Weinreb R, Aung T, Medeiros F . The pathophysiology and treatment of glaucoma: a review. JAMA. 2014; 311(18):1901-11. PMC: 4523637. DOI: 10.1001/jama.2014.3192. View

Tham Y, Li X, Wong T, Quigley H, Aung T, Cheng C . Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014; 121(11):2081-90. DOI: 10.1016/j.ophtha.2014.05.013. View

10.

Pascolini D, Mariotti S . Global estimates of visual impairment: 2010. Br J Ophthalmol. 2011; 96(5):614-8. DOI: 10.1136/bjophthalmol-2011-300539. View

11.

SooHoo J, Golas L, Marando C, Seibold L, Pantcheva M, Ramulu P . Glaucoma Patient Treatment Preferences. Ophthalmology. 2016; 123(7):1621-2. DOI: 10.1016/j.ophtha.2016.01.018. View

12.

Tamrat L, Gessesse G, Gelaw Y . Adherence to topical glaucoma medications in Ethiopian patients. Middle East Afr J Ophthalmol. 2015; 22(1):59-63. PMC: 4302478. DOI: 10.4103/0974-9233.148350. View

13.

Kesav N, Capitena Young C, Ertel M, Seibold L, Kahook M . Sustained-release drug delivery systems for the treatment of glaucoma. Int J Ophthalmol. 2021; 14(1):148-159. PMC: 7790669. DOI: 10.18240/ijo.2021.01.21. View

14.

Rafiei F, Tabesh H, Farzad F . Sustained subconjunctival drug delivery systems: current trends and future perspectives. Int Ophthalmol. 2020; 40(9):2385-2401. DOI: 10.1007/s10792-020-01391-8. View

15.

Wang B, Lin M, Nguyen T, Turalba A . Patient attitudes toward novel glaucoma drug delivery approaches. Digit J Ophthalmol. 2019; 24(2):16-23. PMC: 6380257. DOI: 10.5693/djo.01.2018.07.001. View

16.

Novack G, Barnett M . Ocular Drug Delivery Systems Using Contact Lenses. J Ocul Pharmacol Ther. 2020; 36(8):595-601. DOI: 10.1089/jop.2020.0024. View

17.

Abdull M, Gilbert C, Evans J . Primary open angle glaucoma in northern Nigeria: stage at presentation and acceptance of treatment. BMC Ophthalmol. 2015; 15:111. PMC: 4546340. DOI: 10.1186/s12886-015-0097-9. View

18.

Dreer L, Girkin C, Mansberger S . Determinants of medication adherence to topical glaucoma therapy. J Glaucoma. 2011; 21(4):234-40. PMC: 3183317. DOI: 10.1097/IJG.0b013e31821dac86. View

19.

Bengani L, Hsu K, Gause S, Chauhan A . Contact lenses as a platform for ocular drug delivery. Expert Opin Drug Deliv. 2013; 10(11):1483-96. DOI: 10.1517/17425247.2013.821462. View

20.

Gupta R, Patil B, Shah B, Bali S, Mishra S, Dada T . Evaluating eye drop instillation technique in glaucoma patients. J Glaucoma. 2011; 21(3):189-92. DOI: 10.1097/IJG.0b013e31820bd2e1. View